Skip to main content
Erschienen in:

18.03.2021 | Original Article

India’s performance in controlling Visceral Leishmaniasis as compared to Brazil over past three decades: findings from global burden of disease study

verfasst von: Deepak Dhamnetiya, Ravi Prakash Jha, Shalini, Krittika Bhattacharyya

Erschienen in: Journal of Parasitic Diseases | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Visceral leishmaniasis (VL) is a neglected tropical disease which contributes to the mortality and morbidity significantly in India and Brazil. This study was planned to compare the trends of incidence, prevalence, death and disability-adjusted life years (DALY) of VL burden in India and Brazil from 1990 to 2019 using Global burden of disease study (GBD) data. The metrics are presented as age-standardized rates per 100,000 inhabitants with their respective uncertainty intervals (95% UI) and relative percentages of change. The decline in the Incidence rate is more in case of India (16.82 cases per 100,000 in 1990 to 0.60 cases in 2019) as compared to Brazil (3.12 cases per 100,000 in 1990 to 2.65 cases in 2019). The annualized rate of change in number of prevalent cases for India is − 0.95 (95% UI − 0.98 to − 0.91) whereas for Brazil it is − 0.06 (95% UI − 0.41 to 0.52). The annualized rate of change in number of DALY for India is − 0.94 (95% UI − 0.96 to − 0.92) whereas for Brazil it is − 0.09 (95% UI − 0.25 to 0.28). The annualized rate of change in number of deaths for India is − 0.93 (95% UI − 0.95 to − 0.92) whereas for Brazil it is increasing i.e. 0.04 (95% UI − 0.12 to 0.51). India achieves significant reduction in the age standardized incidence, prevalence, mortality and DALY of VL as compared to Brazil during the period of 1990 to 2019. A multi-centric study is required to assess bottleneck in the existing strategies of VLSCP in Brazil.
Literatur
Zurück zum Zitat Alvar J, Molina R, San Andre´s M, Tesouro M, Nieto J, Vitutia M, et al (1994) Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol 88:371–378CrossRef Alvar J, Molina R, San Andre´s M, Tesouro M, Nieto J, Vitutia M, et al (1994) Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol 88:371–378CrossRef
Zurück zum Zitat Berman JD (1997) Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24:684–703CrossRef Berman JD (1997) Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24:684–703CrossRef
Zurück zum Zitat da Rocha ICM, Dos Santos LHM, Coura-Vital W, da Cunha GMR, Magalhães FDC, da Silva TAM (2018) Effectiveness of the Brazilian Visceral Leishmaniasis Surveillance and Control Programme in reducing the prevalence and incidence of Leishmania infantum infection. Parasit Vectors 11:586CrossRef da Rocha ICM, Dos Santos LHM, Coura-Vital W, da Cunha GMR, Magalhães FDC, da Silva TAM (2018) Effectiveness of the Brazilian Visceral Leishmaniasis Surveillance and Control Programme in reducing the prevalence and incidence of Leishmania infantum infection. Parasit Vectors 11:586CrossRef
Zurück zum Zitat Dhiman RC, Raghavendra K, Kumar V, Kesari S, Kishore K (2003) Susceptibility status of Phlebotomusargentipes to insecticide in districts Vaishali and Patna. J Commun Dis 35:49–51PubMed Dhiman RC, Raghavendra K, Kumar V, Kesari S, Kishore K (2003) Susceptibility status of Phlebotomusargentipes to insecticide in districts Vaishali and Patna. J Commun Dis 35:49–51PubMed
Zurück zum Zitat Foreman KJ, Lozano R, Lopez AD, Murray CJ (2012) Modeling causes of death: an integrated approach using CODEm. Popul Health Metr 10:1CrossRef Foreman KJ, Lozano R, Lopez AD, Murray CJ (2012) Modeling causes of death: an integrated approach using CODEm. Popul Health Metr 10:1CrossRef
Zurück zum Zitat GBD (2019) Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020). Lancet 396:1204–1222 GBD (2019) Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020). Lancet 396:1204–1222
Zurück zum Zitat Kishore K, Kumar V, Kesari S, Dinesh DS, Kumar AJ, Das P et al (2006) Vector control in leishmaniasis. Indian J Med Res 123:467–472PubMed Kishore K, Kumar V, Kesari S, Dinesh DS, Kumar AJ, Das P et al (2006) Vector control in leishmaniasis. Indian J Med Res 123:467–472PubMed
Zurück zum Zitat Lainson R, Shaw JJ (1978) Epidemiology and ecology of leishmaniasis in Latin-America. Nature 273:595–600CrossRef Lainson R, Shaw JJ (1978) Epidemiology and ecology of leishmaniasis in Latin-America. Nature 273:595–600CrossRef
Zurück zum Zitat Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128CrossRef Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128CrossRef
Zurück zum Zitat Mathur P, Samantaray JC, Vajpayee M, Samanta P (2006) Visceral leishmaniasis/human immunodeficiency virus co-infection in India: The focus of two epidemics. J Med Microbiol 55:919–922CrossRef Mathur P, Samantaray JC, Vajpayee M, Samanta P (2006) Visceral leishmaniasis/human immunodeficiency virus co-infection in India: The focus of two epidemics. J Med Microbiol 55:919–922CrossRef
Zurück zum Zitat Mubayi A, Castillo-Chavez C, Chowell G, Kribs-Zaleta C, Ali Siddiqui N, Kumar N et al (2010) Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar. J TheorBiol 262:177–185 Mubayi A, Castillo-Chavez C, Chowell G, Kribs-Zaleta C, Ali Siddiqui N, Kumar N et al (2010) Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar. J TheorBiol 262:177–185
Zurück zum Zitat Muniaraj M (2014) The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? Trop Parasitol 4(1):10–19CrossRef Muniaraj M (2014) The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? Trop Parasitol 4(1):10–19CrossRef
Zurück zum Zitat Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C et al (2012) GBD 2010: design, definitions, and metrics. Lancet 380:2063–2066CrossRef Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C et al (2012) GBD 2010: design, definitions, and metrics. Lancet 380:2063–2066CrossRef
Zurück zum Zitat Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA et al (2014) Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:1005–1070CrossRef Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA et al (2014) Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:1005–1070CrossRef
Zurück zum Zitat Singh R, Das RK, Sharma SK (2001) Resistance of sandflies to DDT in Kala-azar endemic districts of Bihar in India. Bull World Health Organ 79:793PubMedPubMedCentral Singh R, Das RK, Sharma SK (2001) Resistance of sandflies to DDT in Kala-azar endemic districts of Bihar in India. Bull World Health Organ 79:793PubMedPubMedCentral
Zurück zum Zitat Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R et al (2011) Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India. Clin Infect Dis 53:e91–e98CrossRef Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R et al (2011) Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India. Clin Infect Dis 53:e91–e98CrossRef
Zurück zum Zitat Sundar S, Chakravarty J (2012) Recent advances in the diagnosis and treatment of kala-azar. Natl Med J India 25:85–91PubMed Sundar S, Chakravarty J (2012) Recent advances in the diagnosis and treatment of kala-azar. Natl Med J India 25:85–91PubMed
Zurück zum Zitat Thakur CP (2007) A new strategy for elimination of kala-azar from rural Bihar. Indian J Med Res 126:447–451PubMed Thakur CP (2007) A new strategy for elimination of kala-azar from rural Bihar. Indian J Med Res 126:447–451PubMed
Zurück zum Zitat Thakur CP, Kumar M, Pandey AK (1991) Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate. Indian J Med Res 93:103–110PubMed Thakur CP, Kumar M, Pandey AK (1991) Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate. Indian J Med Res 93:103–110PubMed
Zurück zum Zitat Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK (1993) Amphotericin B in resistant kala-azar in Bihar. Natl Med J India 6:57–60PubMed Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK (1993) Amphotericin B in resistant kala-azar in Bihar. Natl Med J India 6:57–60PubMed
Zurück zum Zitat Thakur CP, Meenakshi Thakur AK, Thakur S (2009) Newer strategies for the kala-azar elimination programme in India. Indian J Med Res 129:102–104PubMed Thakur CP, Meenakshi Thakur AK, Thakur S (2009) Newer strategies for the kala-azar elimination programme in India. Indian J Med Res 129:102–104PubMed
Zurück zum Zitat Werneck GL (2014) Visceral leishmaniasis in Brazil: Rationale and concerns related to reservoir control. Rev Saude Publica 48(5):851–856CrossRef Werneck GL (2014) Visceral leishmaniasis in Brazil: Rationale and concerns related to reservoir control. Rev Saude Publica 48(5):851–856CrossRef
Zurück zum Zitat Werneck GL, Costa CHN, de Carvalho FAA, Pires e Cruz MdS, Maguire JH, et al (2014) Effectiveness of insecticide spraying and culling of dogs on the incidence of Leishmaniainfantum infection in humans: a cluster randomized trial in Teresina. Brazil. PLoS Negl Trop Dis 8(10):e3172CrossRef Werneck GL, Costa CHN, de Carvalho FAA, Pires e Cruz MdS, Maguire JH, et al (2014) Effectiveness of insecticide spraying and culling of dogs on the incidence of Leishmaniainfantum infection in humans: a cluster randomized trial in Teresina. Brazil. PLoS Negl Trop Dis 8(10):e3172CrossRef
Zurück zum Zitat World Health Organization. (2007) Report of the fifth consultative meeting on leishmania-HIV coinfection, Addis Ababa, Ethiopia, 20–22 March 2007 (No. WHO/CDS/NTD/IDM/2007.5). World Health Organization World Health Organization. (2007) Report of the fifth consultative meeting on leishmania-HIV coinfection, Addis Ababa, Ethiopia, 20–22 March 2007 (No. WHO/CDS/NTD/IDM/2007.5). World Health Organization
Metadaten
Titel
India’s performance in controlling Visceral Leishmaniasis as compared to Brazil over past three decades: findings from global burden of disease study
verfasst von
Deepak Dhamnetiya
Ravi Prakash Jha
Shalini
Krittika Bhattacharyya
Publikationsdatum
18.03.2021
Verlag
Springer India
Erschienen in
Journal of Parasitic Diseases / Ausgabe 4/2021
Print ISSN: 0971-7196
Elektronische ISSN: 0975-0703
DOI
https://doi.org/10.1007/s12639-021-01375-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

"Die Erektionsstörung ist keine isolierte Erkrankung"

Werden Erektionsstörungen gut behandelt (und das ist möglich), steigt die Lebensqualität enorm. Tipps für eine gute Kommunikation mit den Patienten gibt Androloge Dr. med. Jann-Frederik Cremers in dieser Folge. Welche Fragen sollten gestellt und an welche Ursachen gedacht werden? Und was ist zu tun, wenn PDE-5-Hemmer und Lebensstilveränderungen nicht ausreichend wirken?

Lp(a) zur Risikoeinschätzung bei Thoraxschmerzen

Der Lp(a)-Wert kann dazu beitragen, bei stabilen Patienten mit neu aufgetretenen Thoraxschmerzen und ohne KHK-Diagnose die Wahrscheinlichkeit für das Vorliegen von Koronarstenosen abzuschätzen.

Finerenon bei eGFR-Verlust nicht gleich absetzen!

Der Mineralokortikoid-Rezeptor-Antagonist Finerenon verbessert die Prognose bei Herzinsuffizienz mit leicht reduzierter oder erhaltener Ejektionsfraktion. Ein Rückgang der eGFR zu Beginn der Therapie scheint diese Wirkung nicht wesentlich zu mindern.

Polypen bei nahen Verwandten – erhöhtes Darmkrebsrisiko

Werden bei erstgradigen Verwandten gutartige Darmpolypen identifiziert, ist das Risiko, selbst an einem Kolorektalkarzinom zu erkranken, deutlich erhöht – vor allem das für eine früh beginnende Erkrankung. Hier könnte sich eine frühe Koloskopie besonders lohnen.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.